Connect with us

Hi, what are you looking for?

SecurityWeekSecurityWeek

Cybercrime

Microsoft: Russian, North Korean Hackers Target Vaccine Work

Microsoft said it has detected attempts by state-backed Russian and North Korean hackers to steal valuable data from leading pharmaceutical companies and vaccine researchers.

It said in a blog post Friday that most of the attacks in recent months were unsuccessful, but provided no information on how many succeeded or how serious those breaches were.

Microsoft said it has detected attempts by state-backed Russian and North Korean hackers to steal valuable data from leading pharmaceutical companies and vaccine researchers.

It said in a blog post Friday that most of the attacks in recent months were unsuccessful, but provided no information on how many succeeded or how serious those breaches were.

Chinese state-backed hackers have also been targeting vaccine-makers, the U.S. government said in July while announcing criminal charges.

Microsoft said most of the targets — located in Canada, France, India, South Korea and the United States — were “directly involved in researching vaccines and treatments for COVID-19.” It did not name the targets but said most had vaccine candidates in various stages of clinical trials.

The company identified one of the state-backed hacker groups as Fancy Bear, the Russian military agents who Britain’s National Cyber Security Center said in July were behind such intrusion attempts. Two others were North Korea’s Lazarus Group and a group Microsoft calls Cerium.

Most of the break-in efforts involved attempts to steal the login credentials of people associated with the targeted organizations. The Lazarus Group posed as job recruiters while Cerium targeted spear-phishing emails that masqueraded as missives from World Health Organization representatives, Microsoft said.

Advertisement. Scroll to continue reading.

The blog post coincided with an appearance by Microsoft president Brad Smith at an international forum calling on nations to protect health care facilities from cyberattacks. This year, the Paris Peace Forum is taking place online.

Optimism about a COVID-19 vaccine has grown since pharmaceutical giant Pfizer announced earlier this week that preliminary data showed its vaccine to be 90% effective.

At the same time, coronavirus cases are surging. In the U.S., deaths per day have soared more than 40% over the past two weeks to an average of more than 1,100, the highest level in three months.

RelatedChinese Hackers ‘Stole Data From Spanish Vaccine Labs’: Report

Written By

Daily Briefing Newsletter

Subscribe to the SecurityWeek Email Briefing for the latest cybersecurity threats, trends, and expert insights.

Click to comment

Trending

Daily Briefing Newsletter

Subscribe to the SecurityWeek Email Briefing to stay informed on the latest threats, trends, and technology, along with insightful columns from industry experts.

Today’s attackers are no longer breaking in — they’re logging in. Join this live webinar as we break down the modern identity attack chain and examine how recent breaches exploited weaknesses in authentication, identity verification, and access management processes.

Register

AI has accelerated both sides of the fight. Adversaries are weaponizing vulnerabilities faster, while defenders are racing to ship detections and configurations. Join this live webinar as we explore how to prove your controls actually hold against new threats, map your security maturity, and unite breach simulation with automated pentesting into a single, coordinated program.

Register

People on the Move

Stephen Garcia has been named Chief Information Security Officer at BreachRx.

Kasper Lindgaard has been appointed Vice President of Security Strategy at CoreView.

Chaim Mazal has been named Chief Information Security Officer at GitLab.

More People On The Move

Expert Insights

Daily Briefing Newsletter

Subscribe to the SecurityWeek Email Briefing to stay informed on the latest cybersecurity news, threats, and expert insights. Unsubscribe at any time.